Dimension Therapeutics, Inc. Stock Split Ratio
Dimension Therapeutics, Inc. had Stock Split Ratio of 34.21% as of 2015-10-09, per its 10-K filed 2017-03-09.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2017-03-09
- 2015-10-09: Stockholders' Equity Note, Stock Split, Conversion Ratio 34.21%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2015-10-09 | 34.21% 10-K · filed 2017-03-09 |